Cargando…

Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type

Deceased after circulatory death (DCD) donors offer a viable solution to the current organ shortage, particularly the Maastricht Class III (arrest subsequent to cessation of life support in the hospital). Although current results from these donors are very satisfactory, the number of included donors...

Descripción completa

Detalles Bibliográficos
Autores principales: Soussi, David, Rod, Xavier, Thuillier, Raphael, Leblanc, Suzanne, Goujon, Jean-Michel, Barrou, Benoit, Hauet, Thierry, Kerforne, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745153/
https://www.ncbi.nlm.nih.gov/pubmed/31565655
http://dx.doi.org/10.1155/2019/5924101
_version_ 1783451497213722624
author Soussi, David
Rod, Xavier
Thuillier, Raphael
Leblanc, Suzanne
Goujon, Jean-Michel
Barrou, Benoit
Hauet, Thierry
Kerforne, Thomas
author_facet Soussi, David
Rod, Xavier
Thuillier, Raphael
Leblanc, Suzanne
Goujon, Jean-Michel
Barrou, Benoit
Hauet, Thierry
Kerforne, Thomas
author_sort Soussi, David
collection PubMed
description Deceased after circulatory death (DCD) donors offer a viable solution to the current organ shortage, particularly the Maastricht Class III (arrest subsequent to cessation of life support in the hospital). Although current results from these donors are very satisfactory, the number of included donors is too low and future expansion of inclusion criteria will likely decrease organ quality, with negative consequences on the complication rate. This donor type thus represents a priority in terms of scientific exploration, so as to study it in controlled settings and prepare for future challenges. Hence, we mimicked the DCD Class III clinical conditions a Large White pig model. Herein, we detail the different strategies attempted to attain our objectives, including technical approaches such as animal positioning and ventilator settings, as well as pharmacological intervention to modulate blood pressure and heart rate. We highlight the best combination of factors to successfully reproduce DCD Class III conditions, with perfusion pressures and functional warm ischemia (hypoperfusion) closely resembling clinical situations. Finally, we detail the functional and histological impacts of these conditions. Such a model could be of critical value to explore novel management alternative for these donors, presenting a uniquely adapted platform for such therapeutics as normothermic regional circulation and/or pharmacological intervention.
format Online
Article
Text
id pubmed-6745153
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67451532019-09-29 Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type Soussi, David Rod, Xavier Thuillier, Raphael Leblanc, Suzanne Goujon, Jean-Michel Barrou, Benoit Hauet, Thierry Kerforne, Thomas Biomed Res Int Research Article Deceased after circulatory death (DCD) donors offer a viable solution to the current organ shortage, particularly the Maastricht Class III (arrest subsequent to cessation of life support in the hospital). Although current results from these donors are very satisfactory, the number of included donors is too low and future expansion of inclusion criteria will likely decrease organ quality, with negative consequences on the complication rate. This donor type thus represents a priority in terms of scientific exploration, so as to study it in controlled settings and prepare for future challenges. Hence, we mimicked the DCD Class III clinical conditions a Large White pig model. Herein, we detail the different strategies attempted to attain our objectives, including technical approaches such as animal positioning and ventilator settings, as well as pharmacological intervention to modulate blood pressure and heart rate. We highlight the best combination of factors to successfully reproduce DCD Class III conditions, with perfusion pressures and functional warm ischemia (hypoperfusion) closely resembling clinical situations. Finally, we detail the functional and histological impacts of these conditions. Such a model could be of critical value to explore novel management alternative for these donors, presenting a uniquely adapted platform for such therapeutics as normothermic regional circulation and/or pharmacological intervention. Hindawi 2019-09-03 /pmc/articles/PMC6745153/ /pubmed/31565655 http://dx.doi.org/10.1155/2019/5924101 Text en Copyright © 2019 David Soussi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Soussi, David
Rod, Xavier
Thuillier, Raphael
Leblanc, Suzanne
Goujon, Jean-Michel
Barrou, Benoit
Hauet, Thierry
Kerforne, Thomas
Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type
title Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type
title_full Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type
title_fullStr Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type
title_full_unstemmed Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type
title_short Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type
title_sort preclinical modeling of dcd class iii donation: paving the way for the increased use of this challenging donor type
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745153/
https://www.ncbi.nlm.nih.gov/pubmed/31565655
http://dx.doi.org/10.1155/2019/5924101
work_keys_str_mv AT soussidavid preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype
AT rodxavier preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype
AT thuillierraphael preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype
AT leblancsuzanne preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype
AT goujonjeanmichel preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype
AT barroubenoit preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype
AT hauetthierry preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype
AT kerfornethomas preclinicalmodelingofdcdclassiiidonationpavingthewayfortheincreaseduseofthischallengingdonortype